YAZJI SALIM (Chief Medical Officer) purchased 17.9% of their position (25K shares) of ONCTERNAL THERAPEUTICS, INC. on the open market
Open‑market purchase worth $7.2K — a significant purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 4/14/2023ACC: 0001209191-23-024371
Officer· Chief Medical Officer
Since May 2021
+25K
Net shares
Net buyer
$7.2K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
25K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+10K
Price / share
$0.28
Trade value
$2.85K
% of position
7.2%
4/12/2023
139.68K→149.68K
Common Stock
Direct
Shares
+10K
Price / share
$0.28
Trade value
$2.85K
% of position
6.7%
4/13/2023
149.68K→159.68K
Common Stock
Direct
Shares
+5K
Price / share
$0.30
Trade value
$1.50K
% of position
3.1%
4/14/2023
159.68K→164.68K
Total
Net shares
+25K
Net value
$7.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/12/2023 | P · Purchase | +10K | $0.28 | $2.85K | 7.2% | 139.68K | 149.68K |
| Common Stock Direct | 4/13/2023 | P · Purchase | +10K | $0.28 | $2.85K | 6.7% | 149.68K | 159.68K |
| Common Stock Direct | 4/14/2023 | P · Purchase | +5K | $0.30 | $1.50K | 3.1% | 159.68K | 164.68K |
| Total | +25K | $7.20K | ||||||
Derivative Transactions0
No derivative transactions reported